From assistant professors to biotechs, everyone wants something eye-catching on their website's homepage. You can see here that the artistic style is really customized to the project. 

This image was made for a biotech company whose strategy of linking up growth factors led to a velcro-like multivalent effect that increased the output they sought. 

This image was made for a biotech company whose strategy of linking up growth factors led to a velcro-like multivalent effect that increased the output they sought. 

The Nomura Lab at UC Berkeley opened for business in 2011 with this illustration on their website to highlight their work on metabolic pathways and how perturbations at specific sites can cause all sorts of problems for us. 

The Nomura Lab at UC Berkeley opened for business in 2011 with this illustration on their website to highlight their work on metabolic pathways and how perturbations at specific sites can cause all sorts of problems for us. 

The Streiter Lab at the University of Wisconsin, Madison was looking to add some graphic art to their homepage. They study the mechanisms whereby proteins get tagged for destruction.

The Streiter Lab at the University of Wisconsin, Madison was looking to add some graphic art to their homepage. They study the mechanisms whereby proteins get tagged for destruction.

The Weerapana Lab at Boston College uses mass spectrometry along with molecules they've designed to react selectively. With these tools they can discover and understand the roles of previously unknown enzymes and enzyme activities.

The Weerapana Lab at Boston College uses mass spectrometry along with molecules they've designed to react selectively. With these tools they can discover and understand the roles of previously unknown enzymes and enzyme activities.

These are buttons I designed for Minerva Biotechnologies' website. Their platforms include cancer therapeutics, gold nanoparticles, and stem cell reagents.

These are buttons I designed for Minerva Biotechnologies' website. Their platforms include cancer therapeutics, gold nanoparticles, and stem cell reagents.

This image details Minerva's gold nanoparticle technology.

This image details Minerva's gold nanoparticle technology.

And this one illustrates Minerva's strategy for targeting a key growth regulator in certain types of cancer.

And this one illustrates Minerva's strategy for targeting a key growth regulator in certain types of cancer.

Click on an image below to explore another portfolio page.